A Pilot Study of an Online HIV Stigma Training for Nursing Students in Iran
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jul 17, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new online training program aimed at reducing stigma related to HIV among nursing students in Iran. The main goal is to see if this training can help nursing students develop more positive attitudes and behaviors toward patients living with HIV during clinical practice, compared to a different training that focuses only on the facts and numbers about HIV without addressing stigma.
To participate in this study, you need to be a nursing student in your third or fourth year at Kerman Medical University. If you're in your first or second year or studying a different field at another university, you won't be eligible. If you join, you can expect to take part in online training sessions and help researchers understand how effective the training is in changing attitudes towards HIV. This study is currently recruiting participants, and your involvement could help improve the way future healthcare providers interact with patients living with HIV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Currently nursing students in their year 3 or 4 of training
- • Kerman Medical University (KMU) nursing schools
- Exclusion Criteria:
- • Nursing student in their year 1 and 2
- • Students of other fields and other universities
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kerman, , Iran, Islamic Republic Of
Patients applied
Trial Officials
Ali Mirzazadeh, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported